Celéri Health Announces Enrollment of First Patient in Study of Real World Outcomes® for Medtronic DTM™ Spinal Cord Stimulation (SCS)

February 2021 – 

PRESS RELEASE – February 22, 2021, Conshohocken, PA – Celéri Health, a leader in using Real World Outcomes® to change the paradigm of care for people living with chronic pain, today announced the first patient has been enrolled in the UPGRADE Study, which is a large registry of patients using DTM™ Spinal Cord Stimulation (SCS) available only on the Medtronic Intellis™ platform. The first patient was enrolled on January 29, 2021 at Jax Spine & Pain Centers in Jacksonville, Florida by Dr. Michael Hanes.  The UPGRADE registry will capture long-term, real-world outcomes to understand the effect of DTM SCS programming in the SCS implanted population on the management of chronic pain, primarily on its use for trunk and/or limb pain. The clinical study is sponsored by Celéri Health and is supported by Medtronic’s External Research Program. The registry study will be conducted across approximately 20-30 centers in the United States with up to 1700 patients enrolled. here: https://www.globenewswire.com/news-release/2021/02/23/2180427/0/en/Cel%C3%A9ri-Health-Announces-Enrollment-of-First-Patient-in-Study-of-Real-World-Outcomes-for-Medtronic-DTM-Spinal-Cord-Stimulation-SCS.html 


Schedule demo
Please schedule a time that works for you and we will connect with you to provide a demo.
Let us know how to reach you and we will be in touch within 24 hours.
Ask us anything
Talk to us
Let us know how to reach you and we will be in touch within 24 hours
Apply now
File type: doc, docx, pdf, xls, xlsx. File size: 10Mb.
Request sent
"Thank you for your inquiry, we will be in touch within 24 hours."